SURVYR

THC

Tenet Healthcare Corporation
$262.05
−$6.90 (2.57%)Oct 27 close
Health CareS&P 400 CompareTechnicals
1M3M6M1Y2Y
-27%-13%+2%+16%+31%Oct 2025Oct 2026Apr 202652w high $283.0552w low $157.58
THCSPY
Wall St. Highest PT $315.00 (+20.2%) Wall St. Avg PT $286.41 (+9.3%)
$161$202$243$284$324POC $191Hi $315Avg $286
Underwater Drawdown %Max DD -34.1%Current -6.7%
0.0%-34.1%
Relative Strength vs SPY+7.7% vs SPYOutperforming
+42%0%-42%
1W
−$10.27 (3.77%)
1M
+$2.34 (0.90%)
3M
−$0.58 (0.22%)
6M
+$84.55 (47.63%)
YTD
+$63.33 (31.87%)
1Y
+$45.88 (21.22%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
23 analysts · mean score 1.57
1 = Strong Buy · 5 = Sell
Strong Buy522%
Buy1461%
Hold417%
Underperform00%
Sell00%
Wall Street consensus
Analyst price targets
Current price$262.05
Average target$286.41
+$24.36 (+9.3%) upsideaverage target vs current price
CurrentAverageMedian
Low$260.00
Median$286.41
High$315.00
12-month Wall Street target range
Recent analyst rating changes · 30
Reiterated
2026-10-16 · Guggenheim reiterated Buy on THC
Initiated
2026-09-23 · BMO Capital started covering THC at Market Perform
Reiterated
2026-09-18 · Leerink Partners reiterated Outperform on THC
Reiterated
2026-08-03 · Wells Fargo reiterated Overweight on THC
Reiterated
2026-07-28 · Truist Securities reiterated Buy on THC
Reiterated
2026-07-28 · Baird reiterated Neutral on THC
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$21.6B
P/E (last 12 months)10.3
P/E (next 12 months, estimated)12.7
52-week range$157.58 – $283.05
Revenue growth (latest quarter vs a year ago)+6.8%
Dividend yieldNo dividend
Analyst consensusBuy (22)
Average analyst price target$286.41 (+9%)

What they do

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Healthcare · Medical Care Facilities
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
56th percentile in sector
C+
12-1 return: +23.8%
Percentile within its GICS sector across the S&P 1500.
Growth
41st percentile in sector
C
Revenue growth (YoY): +6.8%
Percentile within its GICS sector across the S&P 1500.
Value
83rd percentile in sector
A-
Forward E/P: 7.9% · EBITDA/EV: 13.2%
Percentile within its GICS sector across the S&P 1500.
Profitability
75th percentile in sector
B+
Profit margin: +10.3% · Return on equity: +37.3%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

THC earningsReports tomorrow
Next report · quarter Sep 2026
Thu Oct 29, 2026Before the open
EPS consensus$4.68 range $4.03–$5.11
Revenue consensus$5.5B 19 analysts
Last 4 quarters · EPS vs estimate
Jul 23, 2026$6.12est $4.26+43.5%Above estimates
Apr 30, 2026$4.82est $4.17+15.7%Above estimates
Feb 11, 2026$4.70est $4.07+15.6%Above estimates
Oct 28, 2025$3.70est $3.35+10.5%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-27 18:23:24 ET
24-1025-0225-0425-0725-1026-0226-0426-070.006.12
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$6.0B+14.6%
2026-03-31$5.8B–
2025-12-31$5.5B–
2025-09-30$5.3B–
2025-06-30$5.3B–

Recent dividends

2000-03-13: $0.027 · 1993-08-16: $0.320 · 1993-05-17: $0.320 · 1993-02-12: $0.320 · 1992-11-06: $0.320 · 1992-08-10: $0.320 · 1992-05-11: $0.307 · 1992-02-10: $0.307

News & catalysts

More news
HCA Healthcare Sickens Hospital Stocks With 2027 Outlook
Investor's Business Daily · 14h ago
Rating changes
Reiterated
2026-10-16 · Guggenheim reiterated Buy on THC
Initiated
2026-09-23 · BMO Capital started covering THC at Market Perform
Reiterated
2026-09-18 · Leerink Partners reiterated Outperform on THC
Reiterated
2026-08-03 · Wells Fargo reiterated Overweight on THC
Reiterated
2026-07-28 · Truist Securities reiterated Buy on THC
Reiterated
2026-07-28 · Baird reiterated Neutral on THC

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
Kerrey J Robert
Director · 2026-09-14
Sell
$662.1K
Kerrey J Robert
Director · 2026-09-14
Sell
$1.1M
Kerrey J Robert
Director · 2026-09-14
Sell
$1.4M
Mark Richard J
Director · 2026-09-10
Sell
$2.6M
West Nadja
Director · 2026-09-02
Sell
$298.1K
Foo Lisa Y
EVP, Chief Operating Officer · 2026-08-31
Sell
$6.4M
Sutaria Saumya
Director, CEO · 2026-08-25
Sell
$2.2M
Sutaria Saumya
Director, CEO · 2026-08-25
Sell
$6.8M
Sutaria Saumya
Director, CEO · 2026-08-25
Sell
$4.7M
Sutaria Saumya
Director, CEO · 2026-08-24
Sell
$10.2M
Sutaria Saumya
Director, CEO · 2026-08-24
Sell
$3.7M
Haney Cecil D
Director · 2026-08-24
Sell
$361.4K

Stats refreshed 2026-10-27 18:23:24 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026